Login
Bicara Therapeutics Inc. logo

Bicara Therapeutics Inc.

bicara.com

What Do They Do?

Develops cancer treatments for patients with solid tumors, focusing on head and neck and other squamous cell cancers.

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Sep 30, 2026
Net income
▼ −96% (Loss)
vs −$36.3M in Q3 FY2025

Who Do They Compete With?

Competes with Merck &, Eli Lilly &, Merck KGaA, Akeso, AstraZeneca, AVEO Pharmaceuticals, BioAtla, BioNTech, Corbus Pharmaceuticals Holdings, GSK, InhibRx Biosciences, Johnson & Johnson, Merus, PDS Biotechnology, Pyxis Oncology, and Rakuten Medical

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support